benoxinate has been researched along with Parkinson Disease in 1 studies
benoxinate: RN given refers to parent cpd; structure
oxybuprocaine : A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohsaka, M | 1 |
| Oeda, T | 1 |
| Umemura, A | 1 |
| Tomita, S | 1 |
| Park, K | 1 |
| Yamamoto, K | 1 |
| Sugiyama, H | 1 |
| Sawada, H | 1 |
1 other study available for benoxinate and Parkinson Disease
| Article | Year |
|---|---|
Oxybuprocaine for apraxia of lid opening in Parkinson's disease: A placebo-controlled pilot trial.
Topics: Anesthetics, Local; Apraxias; Eyelids; Female; Humans; Male; Parkinson Disease; Pilot Projects; Proc | 2018 |